Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trialMichael R. Migden, Reinhard Dummer, Karl D. Lewis et al.|The Lancet Oncology|2015Cited by 432
The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinomaReinhard Dummer, Michael R. Migden, Alexander Guminski et al.|Journal of the American Academy of Dermatology|2016Cited by 163